Jade Biosciences JBIO
NASDAQ JBIO
$16.40 +0.80 (+5.13%)
At close: Nov 10, 2026 · 4:00 PM EST

Jade Biosciences (JBIO) Preferred Stock Liabilities (2021 - 2025)

Updated

Jade Biosciences (JBIO) reported Preferred Stock Liabilities of $2,000 for Q1 2025, down 50.0% from the prior quarter.

Analysis

Jade Biosciences (JBIO) Preferred Stock Liabilities (2021 - 2025) Analysis & Trends

At the end of FY2024, Jade Biosciences posted Preferred Stock Liabilities of $4,000.

  • Five-year quarterly Preferred Stock Liabilities spans a low of $2,000 in Q2 2024 and a high of $4,000 in Q4 2024.
  • Per Business Quant data, the three quarters before Q1 2025 came in at $4,000 (Q4 2024), $2,000 (Q3 2024) and $2,000 (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Jade Biosciences 1.04 Bn -265.30 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 2,000.00
Mar 31, 2025 2,000.00
Dec 31, 2024 4,000.00
Sep 30, 2024 2,000.00
Jun 30, 2024 2,000.00
Dec 31, 2021 12.29 Mn
API Access

Jade Biosciences Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=JBIO&period=max&api_key=YOUR_API_KEY